These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9285901)

  • 1. Structure-function relationships in diabetic nephropathy: lessons and limitations.
    Adler S
    Kidney Int Suppl; 1997 Sep; 60():S42-5. PubMed ID: 9285901
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
    Ahn JD; Morishita R; Kaneda Y; Kim HJ; Kim YD; Lee HJ; Lee KU; Park JY; Kim YH; Park KK; Chang YC; Yoon KH; Kwon HS; Park KG; Lee IK
    Gene Ther; 2004 Jun; 11(11):916-23. PubMed ID: 14961072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TGF-beta in pathogenesis of diabetic nephropathy.
    Pantsulaia T
    Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does nitric oxide, an inflammatory mediator of glomerular mesangial cells, have a role in diabetic nephropathy?
    Pfeilschifter J
    Kidney Int Suppl; 1995 Sep; 51():S50-60. PubMed ID: 7474691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy].
    Liu Z; Chen Z; Li Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1369-73. PubMed ID: 11930630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of diabetic glomerulosclerosis.
    Del Prete D; Anglani F; Ceol M; D'Angelo A; Forino M; Vianello D; Baggio B; Gambaro G
    Nephrol Dial Transplant; 1998; 13 Suppl 8():20-5. PubMed ID: 9870421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix metabolism in diabetic nephropathy.
    Mason RM; Wahab NA
    J Am Soc Nephrol; 2003 May; 14(5):1358-73. PubMed ID: 12707406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad1 as a biomarker for diabetic nephropathy.
    Kato H; Si H; Hostetter T; Susztak K
    Diabetes; 2008 Jun; 57(6):1459-60. PubMed ID: 18511448
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and molecular pathomechanisms of diabetic nephropathy.
    Thaiss F; Stahl R
    Clin Investig; 1993 Oct; 71(10):830-3. PubMed ID: 8305843
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of cellular glucose transporters in pathogenesis of diabetic nephropathy].
    Witowski J; Breborowicz A
    Przegl Lek; 1999; 56(12):793-9. PubMed ID: 10789192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy.
    McLennan SV; Death AK; Fisher EJ; Williams PF; Yue DK; Turtle JR
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):123-35. PubMed ID: 10099846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
    Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
    Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of glucose signaling in mesangial cells in diabetic nephropathy.
    Haneda M; Koya D; Isono M; Kikkawa R
    J Am Soc Nephrol; 2003 May; 14(5):1374-82. PubMed ID: 12707407
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: a further experimental insight into the pathophysiology of diabetic nephropathy.
    Morano S; Cipriani R; Santangelo C; Fallarino M; Carnovale A; Mandosi E; Gatti A; Sensi M; Di Mario U
    Clin Ter; 2008; 159(3):151-4. PubMed ID: 18594743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.
    Qian Y; Feldman E; Pennathur S; Kretzler M; Brosius FC
    Diabetes; 2008 Jun; 57(6):1439-45. PubMed ID: 18511444
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current questions concerning the pathomechanism of diabetic nephropathy].
    Mogyorósi A; de Châtel R; Ziyadeh FN
    Orv Hetil; 1996 Dec; 137(51):2845-50. PubMed ID: 9679619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangial cell dysfunction.
    Kikkawa R; Haneda M; Koya D; Shigeta Y
    J Diabet Complications; 1991; 5(2-3):58-9. PubMed ID: 1770053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.